BOT — Botanix Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Botanix Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	7.29	10.3	79.3	65	36.6
Net Total Accounts Receivable
Net Total Receivables	0.141	0.489	2.28	3.2	6.64
Total Inventory
Prepaid Expenses
Total Current Assets	10.5	14	82.9	99.6	80.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.179	0.065	0.072	1.38	0.817
Net Intangible Assets
Long Term Investments
Total Assets	14	24.8	112	129	106
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5.89	1.89	3.73	24.9	31
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	5.89	1.89	3.73	47.8	42.5
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	8.15	23	109	81.3	63.5
Total Liabilities & Shareholders' Equity	14	24.8	112	129	106
Total Common Shares Outstanding